Friday 6 November 2026
Export DBD’s income statement to Excel — free account
Diebold Nixdorf, Incorporated
DBD Technology Software Application
Diebold Nixdorf, Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 1.46% from fiscal 2024.
- Revenue
- +5.19%
- EPS
- −81.4%
- Free cash flow
- −346.1%
- Total debt
- +1.64%
Quarter to September 2026, against a year earlier
58.30
0.32
+0.55%
Follow DBD
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 7 | 7 | 7 |
| 9.26% | 10.70% | 10.68% | 7.46% | ||
| 2.56% | 2.89% | 2.97% | 2.08% | ||
ROIC |
9.30% | 9.62% | 9.40% | 7.73% | |
Return on Tangible Assets |
13.49% | 15.66% | 16.66% | 11.52% | |
Average Days of Receivables |
64.14 | 56.50 | 61.48 | 63.31 | |
Free Cash Flow per Share |
6.49 | 7.23 | 6.16 | 3.77 | |
Free Cash Flow |
239.00 | 253.60 | 212.00 | 127.20 | |
Capital Expenditures |
(61.70) | (63.10) | (61.00) | (61.00) | |
| Other line items | |||||
Cash ROIC |
9.72% | 10.84% | 9.63% | 6.12% | |
Accounts Receivable Turnover |
6.05 | 6.43 | 6.19 | 6.22 | |
Accounts Payable Turnover |
6.38 | 6.19 | 6.17 | 6.16 | |
Inventory Turnover |
5.42 | 5.22 | 4.95 | 5.07 | |
Average Days of Payables |
55.32 | 61.07 | 63.83 | 61.17 | |
Days of Inventory on Hand |
66.85 | 69.99 | 75.14 | 69.70 | |
Tax Rate |
(0.19) | (0.22) | (0.28) | (0.33) | |
Research and Development Expense of Revenue |
2.28% | 2.23% | 2.17% | 2.13% | |
Selling, General and Administrative Expense of Revenue |
16.62% | 16.54% | 16.68% | 17.02% | |
Share Based Compensation of Revenue |
0.32% | 0.32% | 0.34% | 0.37% | |
Interest Coverage |
2.82 | 2.80 | 2.74 | 2.23 | |
Operating CF/Net income |
3.18 | 2.94 | 2.46 | 2.45 | |
Depreciation/Fixed assets |
0.47 | 0.45 | 0.43 | 0.42 | |
Capex/Depreciation |
(0.46) | (0.48) | (0.46) | (0.46) | |
Revenue per Share |
103.42 | 109.87 | 112.56 | 116.35 | |
Operating CF per Share |
8.17 | 9.02 | 7.94 | 5.58 | |
Capex per Share |
(1.68) | (1.80) | (1.77) | (1.81) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 2 Nov 2026